Qiagen and Roche Report Spike in MDx Revenues for FY 2010

Qiagen's growth was driven primarily by its infectious disease testing portfolio, while Roche reported strong demand for its virology products and Cobas 4800 molecular diagnostics system.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.